Home / Genomics and Cellular Research / Lateral flow assay development from lab-based assay to diagnostics test prototype

Lateral flow assay development from lab-based assay to diagnostics test prototype

Lateral flow assays are unrivalled among rapid tests when it comes to speed and ease of use. Their development, however, requires highly informed decision making, including careful selection of the nitrocellulose membrane and other key components. Getting this approach right helps speed up the iterative assay development process, leading to an optimal solution that minimizes the risks of late setbacks and costly re-testing and re-validation. Join this webinar to hear:
• A simple introduction to lateral flow tests
• The important factors and considerations for robust design
• Guidance on selecting the correct materials
• FAQs and examples of common issues (and how to resolve)

Speakers:
Lee Jenkins
Senior Product Leader, Cytiva
Lee is part of the Senior Management team within the Whatman business area of Cytiva, with overall responsibility for the performance of a large portfolio of products and services, primarily focused on the diagnostic rapid testing market. Experience of involvement with diagnostic development companies for over 5 years and part of the Cytiva (formerly GE Life Sciences) business for over 9 years.